title: Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation.
authors.affiliation: Second Department of Surgery, Hiroshima University School of Medicine, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Fudaba
authors.forename: Y
authors.initials: Y
authors.lastname: Fukuda
authors.forename: H
authors.initials: H
authors.lastname: Yamamoto
authors.forename: H
authors.initials: H
authors.lastname: Ohdan
authors.forename: S
authors.initials: S
authors.lastname: Shintaku
authors.forename: S
authors.initials: S
authors.lastname: Shibata
authors.forename: Y
authors.initials: Y
authors.lastname: Miyata
authors.forename: S
authors.initials: S
authors.lastname: Marubayashi
authors.forename: T
authors.initials: T
authors.lastname: Asahara
authors.forename: K
authors.initials: K
authors.lastname: Dohi
mesh_terms: D002908:Chronic Disease; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008775:Methylprednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus; D008775:Methylprednisolone